Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration
International Journal of Nanomedicine · 2025-01 · Volume 20 · 367-402
DOI: 10.2147/ijn.s494224 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025-01. Verfasst von Yaswanthi Yanamadala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA. Hauptthemen laut MEDLINE: Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Microbiology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA.
ORCID-Profile: Sangeeta Khare, Kuppan Gokulan
Zitieren
APA
Yanamadala, Y., Muthumula, C. M. R., Khare, S., & Gokulan, K. (2025). Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration. International Journal of Nanomedicine, Volume 20, 367-402. https://doi.org/10.2147/ijn.s494224
Vancouver
Yanamadala Y, Muthumula CMR, Khare S, Gokulan K. Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration. International Journal of Nanomedicine. 2025;Volume 20:367-402. doi:10.2147/ijn.s494224
BibTeX
@article{Yanamadala2025,
author = {Yanamadala, Yaswanthi and Muthumula, Chandra Mohan Reddy and Khare, Sangeeta and Gokulan, Kuppan},
title = {Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration},
journal = {International Journal of Nanomedicine},
year = {2025},
volume = {Volume 20},
pages = {367--402},
doi = {10.2147/ijn.s494224}
}
EUVIMED